CCL2 抗体 (Internal Region)
-
- 抗原 See all CCL2 抗体
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
抗原表位
- Internal Region
-
适用
- 人, 小鼠, 大鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CCL2 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF)
- 特异性
- MCP1 Antibody detects endogenous levels of total MCP1.
- 预测反应
- Horse
- 纯化方法
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- 免疫原
- A synthesized peptide derived from human MCP1, corresponding to a region within the internal amino acids.
- 亚型
- IgG
- Top Product
- Discover our top product CCL2 Primary Antibody
-
-
- 应用备注
- WB 1:1000-3000, IHC 1:200, IF/ICC 1:100-1:500, ELISA(peptide) 1:20000-1:40000
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 mg/mL
- 缓冲液
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20 °C. Stable for 12 months from date of receipt.
- 有效期
- 12 months
-
-
Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction." in: Transplant immunology, Vol. 48, pp. 18-25, (2018) (PubMed).
: "An Extracellular Matrix-Mimicking Hydrogel for Full Thickness Wound Healing in Diabetic Mice." in: Macromolecular bioscience, Vol. 18, Issue 7, pp. e1800047, (2018) (PubMed).
: "[Comparative estimation of antilithogenic activity of porcine kidney derived biomedical substance and sodium citrate in experimental urolithiasis]." in: Urologiia (Moscow, Russia : 1999), Issue 2, pp. 24-27, (2017) (PubMed).
: "Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines." in: Urolithiasis, Vol. 45, Issue 2, pp. 159-175, (2016) (PubMed).
: "
-
Expression and significance of Sirt1 in renal allografts at the early stage of chronic renal allograft dysfunction." in: Transplant immunology, Vol. 48, pp. 18-25, (2018) (PubMed).
-
- 抗原
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
- 别名
- CCL2 (CCL2 产品)
- 别名
- GDCF-2 antibody, HC11 antibody, HSMCR30 antibody, MCAF antibody, MCP-1 antibody, MCP1 antibody, SCYA2 antibody, SMC-CF antibody, AI323594 antibody, JE antibody, Scya2 antibody, Sigje antibody, MCP-1A antibody, MCP1A antibody, C-C motif chemokine ligand 2 antibody, chemokine (C-C motif) ligand 2 antibody, C-C motif chemokine 2 antibody, CCL2 antibody, Ccl2 antibody, LOC101120093 antibody
- 背景
-
Description: Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.
Gene: CCL2
- 分子量
- 14 kDa
- 基因ID
- 6347
- UniProt
- P13500
- 途径
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-